- Home
- SGMT vs PSF Comparison
SGMT vs PSF Comparison
Compare SGMT & PSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- PSF
- Stock Information
- Founded
- SGMT 2006
- PSF 2010
- Country
- SGMT United States
- PSF United States
- Employees
- SGMT N/A
- PSF N/A
- Industry
- SGMT
- PSF Investment Managers
- Sector
- SGMT
- PSF Finance
- Exchange
- SGMT Nasdaq
- PSF Nasdaq
- Market Cap
- SGMT 230.3M
- PSF 245.5M
- IPO Year
- SGMT 2023
- PSF N/A
- Fundamental
- Price
- SGMT $6.15
- PSF $20.96
- Analyst Decision
- SGMT Strong Buy
- PSF
- Analyst Count
- SGMT 7
- PSF 0
- Target Price
- SGMT $26.57
- PSF N/A
- AVG Volume (30 Days)
- SGMT 461.6K
- PSF 25.0K
- Earning Date
- SGMT 11-12-2025
- PSF 01-01-0001
- Dividend Yield
- SGMT N/A
- PSF 7.69%
- EPS Growth
- SGMT N/A
- PSF N/A
- EPS
- SGMT N/A
- PSF N/A
- Revenue
- SGMT N/A
- PSF N/A
- Revenue This Year
- SGMT N/A
- PSF N/A
- Revenue Next Year
- SGMT N/A
- PSF N/A
- P/E Ratio
- SGMT N/A
- PSF N/A
- Revenue Growth
- SGMT N/A
- PSF N/A
- 52 Week Low
- SGMT $1.73
- PSF $16.00
- 52 Week High
- SGMT $11.41
- PSF $20.19
- Technical
- Relative Strength Index (RSI)
- SGMT 30.58
- PSF 73.93
- Support Level
- SGMT $6.77
- PSF $20.58
- Resistance Level
- SGMT $7.35
- PSF $20.60
- Average True Range (ATR)
- SGMT 0.41
- PSF 0.16
- MACD
- SGMT -0.07
- PSF 0.05
- Stochastic Oscillator
- SGMT 5.57
- PSF 82.97
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About PSF Cohen & Steers Select Preferred and Income Fund Inc.
Cohen & Steers Select Preferred and Income Fund Inc is a diversified, closed-end investment company. The Fund's primary investment objective is high current income with capital appreciation as its secondary objective. The Fund invests at least of its Managed Assets in preferred and other income securities issued by U.S. and non-U.S. companies.